Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Ilaria Grazi"'
Autor:
Alain Gelibter, Lucrezia Tuosto, Angela Asquino, Marco Siringo, Arianna Sabatini, Ilaria Grazia Zizzari, Angelica Pace, Fabio Scirocchi, Flavio Valentino, Serena Bianchini, Salvatore Caponnetto, Donatella Paoli, Filippo Bellati, Daniele Santini, Marianna Nuti, Aurelia Rughetti, Chiara Napoletano
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Pembrolizumab (an anti-PD1 antibody) alone or combined with chemotherapy represented the standard of care for advanced non-oncogene addicted non-small cell lung cancer (NSCLC) patients. These therapies induced early modifications of the immune respon
Externí odkaz:
https://doaj.org/article/cf8cc2b2158d42889669bec1e4e0d6bf
Autor:
Monica Ulivelli, Daiana Bezzini, Lucia Kundisova, Ilaria Grazi, Mario Alberto Battaglia, Nicola Nante, Simone Rossi
To evaluate mortality for Parkinson's disease (PD) in Italy during a long time period (1980-2015) and to discuss the role of possible general and specific influencing factors.Based on mortality data provided by the Italian National Institute of Stati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02e924939c325d1d81f9296dbbfb41b2
http://hdl.handle.net/11365/1192421
http://hdl.handle.net/11365/1192421
Autor:
Alain Gelibter, Angela Asquino, Lidia Strigari, Ilaria Grazia Zizzari, Lucrezia Tuosto, Fabio Scirocchi, Angelica Pace, Marco Siringo, Elisa Tramontano, Serena Bianchini, Filippo Bellati, Andrea Botticelli, Donatella Paoli, Daniele Santini, Marianna Nuti, Aurelia Rughetti, Chiara Napoletano
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-16 (2024)
Abstract Background Immune checkpoint inhibitors (ICIs), administered alone or combined with chemotherapy, are the standard of care in advanced non-oncogene addicted Non-Small Cell Lung Cancer (NSCLC). Despite these treatments' success, most long-ter
Externí odkaz:
https://doaj.org/article/3b1cd664555b4d159dbbfd800c53dc3b
Autor:
Angelica Pace, Fabio Scirocchi, Chiara Napoletano, Ilaria Grazia Zizzari, Agnese Po, Francesca Megiorni, Angela Asquino, Paola Pontecorvi, Hassan Rahimi, Cinzia Marchese, Elisabetta Ferretti, Marianna Nuti, Aurelia Rughetti
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-15 (2023)
Abstract Background Fibroblast growth factor receptor (FGFR) gene family alterations are found in several cancers, indicating their importance as potential therapeutic targets. The FGFR-tyrosine kinase inhibitor (TKI) pemigatinib has been introduced
Externí odkaz:
https://doaj.org/article/255236c69f6b466e83fed56613c8381c
Autor:
Silvia Mezi, Giulia Pomati, Giulia Fiscon, Sasan Amirhassankhani, Ilaria Grazia Zizzari, Chiara Napoletano, Aurelia Rughetti, Ernesto Rossi, Giovanni Schinzari, Giampaolo Tortora, Gaetano Lanzetta, Giulia D’Amati, Marianna Nuti, Daniele Santini, Andrea Botticelli
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundThe immune profile of each patient could be considered as a portrait of the fitness of his/her own immune system. The predictive role of the immune profile in immune-related toxicities (irAEs) development and tumour response to treatment wa
Externí odkaz:
https://doaj.org/article/dc54455f60d4429eb31fa7aa6fc746c3
Autor:
Fulvia Ceccarelli, Francesco Natalucci, Alessandra Di Filippo, Giulio Olivieri, Chiara Napoletano, Aurelia Rughetti, Marianna Nuti, Ilaria Grazia Zizzari, Fabrizio Conti
Publikováno v:
Journal of Immunology Research, Vol 2023 (2023)
Objective. The role of T cells in the pathogenesis of systemic lupus erythematosus (SLE) has recently gained attention. Costimulatory molecules are membrane proteins strictly associated with T-cell receptor (TCR), acting by activating or inhibiting T
Externí odkaz:
https://doaj.org/article/0f9d8e1b7a904e55b7e76b2720b57e4d
Autor:
Andrea Botticelli, Giulia Pomati, Alessio Cirillo, Simone Scagnoli, Simona Pisegna, Antonella Chiavassa, Ernesto Rossi, Giovanni Schinzari, Giampaolo Tortora, Francesca Romana Di Pietro, Bruna Cerbelli, Alessandra Di Filippo, Sasan Amirhassankhani, Alessandro Scala, Ilaria Grazia Zizzari, Enrico Cortesi, Silverio Tomao, Marianna Nuti, Silvia Mezi, Paolo Marchetti
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundDespite the efficacy of immunotherapy, only a small percentage of patients achieves a long-term benefit in terms of overall survival. The aim of this study was to define an immune profile predicting the response to immune checkpoint inhibit
Externí odkaz:
https://doaj.org/article/54821067011f43438ba2f1c0c87d0025
Autor:
Ernesto Rossi, Ilaria Grazia Zizzari, Alessandra Di Filippo, Anna Acampora, Monica Maria Pagliara, Maria Grazia Sammarco, Maurizio Simmaco, Luana Lionetto, Andrea Botticelli, Emilio Bria, Paolo Marchetti, Maria Antonietta Blasi, Giampaolo Tortora, Giovanni Schinzari, Marianna Nuti
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 3 (2022)
Metastatic uveal melanoma (UM) is a poor prognosis malignancy. Immunotherapy is commonly employed, despite the low activity, considering the lack of other effective systemic treatments. In this study, the prognostic and predictive role of soluble imm
Externí odkaz:
https://doaj.org/article/2866506a766b4c8a8ddb25fc361fa0d9
Autor:
Fabio Scirocchi, Simone Scagnoli, Andrea Botticelli, Alessandra Di Filippo, Chiara Napoletano, Ilaria Grazia Zizzari, Lidia Strigari, Silverio Tomao, Enrico Cortesi, Aurelia Rughetti, Paolo Marchetti, Marianna Nuti
Publikováno v:
EBioMedicine, Vol 79, Iss , Pp 104010- (2022)
Summary: Background: Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) are innovative small target molecules that, in combination with endocrine therapy, have recently been employed in the treatment of patients with HR+/HER2− metastatic breast cance
Externí odkaz:
https://doaj.org/article/91e990b21f784fe680b1ad00938ec62e
Autor:
Andrea Botticelli, Pamela Vernocchi, Federico Marini, Andrea Quagliariello, Bruna Cerbelli, Sofia Reddel, Federica Del Chierico, Francesca Di Pietro, Raffaele Giusti, Alberta Tomassini, Ottavia Giampaoli, Alfredo Miccheli, Ilaria Grazia Zizzari, Marianna Nuti, Lorenza Putignani, Paolo Marchetti
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-10 (2020)
Abstract Background Despite the efficacy of immune checkpoint inhibitors (ICIs) only the 20–30% of treated patients present long term benefits. The metabolic changes occurring in the gut microbiota metabolome are herein proposed as a factor potenti
Externí odkaz:
https://doaj.org/article/99b3dbdf2f344f43b6e4967bf2f8b467